Ambalal Sarabhai Enterprises Limited
Promoter holding in Ambalal Sarabhai Enterprises Limited was 31.36% in Sep 2026.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 31.36% | 68.64% |
Compared with similar companies
Promoter holding in Ambalal Sarabhai Enterprises Limited is lower than 91% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Ambalal Sarabhai Enterprises Limited | 31.36% |
| Lyka Labs Limited | 58.45% |
| QMS Medical Allied Services Limited | 68.11% |
| Aarey Drugs & Pharmaceuticals Limited | 42.79% |
| Medicamen Biotech Limited | 40.46% |
| Jenburkt Pharmaceuticals Limited | 46.62% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Ambalal Sarabhai Enterprises Limited's promoter holding?
Promoters held 31.36% of Ambalal Sarabhai Enterprises Limited as of 30 Sep 2026, and the public held 68.64%.
Are any promoter shares of Ambalal Sarabhai Enterprises Limited pledged?
No promoter shares are recorded as pledged.
How does Ambalal Sarabhai Enterprises Limited's promoter holding compare with similar companies?
Promoter holding in Ambalal Sarabhai Enterprises Limited is lower than 91% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.